Sunday 18 October 2026
Export GALT’s income statement to Excel — free account
Galectin Therapeutics Inc.
GALT Healthcare Biotechnology
In the quarter to June 2026, EPS fell 16.7%, free cash flow grew 63.1% and total debt fell 13.1%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
3.62
0.09
−2.43%
Follow GALT
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
4.18 | 1.29 | 4.19 | 17.10 | 5.46 | 4.63 | 1.58 | 1.77 | 0.49 | 2.42 |
Net Debt/EBITDA |
0.72 | 0.19 | 0.61 | 3.54 | 1.16 | 0.35 | (0.55) | (1.21) | (1.65) | (5.79) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.11% | 0.03% | 69.45% | 187.12% | 254.40% | 486.48% | 684.70% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.10 | (1.24) | (1.19) | (0.83) | (1.06) |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.73 | 0.91 | 0.68 | 0.54 | 0.87 | 0.79 | 0.80 | 0.74 | 0.88 | 0.77 |
Capex/Depreciation |
0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Coverage |
(477.36) | (1,353.92) | (40.48) | (154.46) | (269.47) | (61.72) | (37.13) | (13.64) | (7.66) | (2.74) |
| (217.67%) | 740.75% | 306.67% | (97.74%) | (72.31%) | (275.21%) | 228.26% | 92.49% | 56.27% | 26.51% | |
| (105.92%) | (175.06%) | (228.56%) | (70.22%) | (60.47%) | (85.96%) | (123.19%) | (181.09%) | (206.59%) | (167.30%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(186.03%) | (2,052.53%) | (223.78%) | (44.46%) | (98.07%) | (93.63%) | (515.56%) | (372.32%) | 259.95% | (271.56%) |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(0.56) | (0.45) | (0.26) | (0.21) | (0.36) | (0.42) | (0.52) | (0.55) | (0.67) | (0.37) |
Cash per Share |
0.53 | 0.09 | 0.21 | 0.91 | 0.48 | 0.68 | 0.31 | 0.43 | 0.24 | 0.28 |
Shareholders Equity per Share |
0.41 | 0.03 | 0.18 | 0.87 | 0.42 | 0.04 | (0.54) | (1.00) | (1.65) | (1.97) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.41 | 0.03 | 0.18 | 0.87 | 0.42 | 0.04 | (0.54) | (1.00) | (1.65) | (1.97) |
Free Cash Flow |
(16.41) | (15.89) | (10.18) | (10.85) | (20.60) | (24.31) | (31.06) | (32.96) | (41.77) | (23.87) |
Working Capital |
12.01 | 0.85 | 6.72 | 45.39 | 24.07 | 32.79 | 7.54 | 12.03 | (18.16) | 11.41 |
Net Current Asset Value |
12.01 | 0.85 | 6.72 | 45.34 | 24.06 | 2.61 | (32.93) | (60.73) | (103.31) | (126.29) |
| Other line items | ||||||||||
Quick Ratio |
4.06 | 1.03 | 3.92 | 16.84 | 5.03 | 4.39 | 1.43 | 1.64 | 0.43 | 2.21 |
Depreciation/Fixed assets |
0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cash ROIC |
(59.94%) | (374.28%) | (67.18%) | (11.65%) | (40.12%) | (34.09%) | (118.42%) | (88.71%) | 1,470.15% | (94.52%) |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.56) | (0.45) | (0.26) | (0.21) | (0.36) | (0.42) | (0.52) | (0.55) | (0.67) | (0.37) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Payables |
0.68 | 0.76 | 0.45 | 0.98 | 1.48 | 1.55 | 2.85 | 5.16 | 6.04 | 4.45 |
Average Assets |
21.10 | 9.98 | 6.58 | 28.74 | 39.03 | 35.71 | 31.56 | 24.74 | 22.85 | 18.51 |
Average Common Equity |
10.27 | (2.36) | (4.91) | 20.65 | 32.64 | 11.15 | (17.03) | (48.45) | (83.88) | (116.85) |
Columns are period end dates